Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001125282-06-001420
Filing Date
2006-03-03
Accepted
2006-03-03 16:40:55
Documents
11
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 10K b411436_10k.txt 10-K 499575
2 EXHIBIT 3(I) b411436ex_3-i.txt EX-3.(I) 35785
3 EXHIBIT 10.3 b411436ex_10-3.txt EX-10.3 51042
4 EXHIBIT 10.23 b411436ex_10-23.txt EX-10.23 2941
5 EXHIBIT 12.1 b411436ex_12-1.txt EX-12.1 3835
6 EXHIBIT 12.2 b411436ex_12-2.txt EX-12.2 660
7 EXHIBIT 23.0 b411436ex_23-0.txt EX-23.0 1852
8 EXHIBIT 31.1 b411436ex_31-1.txt EX-31.1 4645
9 EXHIBIT 31.2 b411436ex_31-2.txt EX-31.2 4730
10 EXHIBIT 32.1 b411436ex_32-1.txt EX-32.1 1852
11 EXHIBIT 32.2 b411436ex_32-2.txt EX-32.2 1969
  Complete submission text file 0001125282-06-001420.txt   610561
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 06664426
SIC: 2836 Biological Products, (No Diagnostic Substances)